Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-30

FDA Approved: ETYQA — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved ETYQA, a generic estradiol and norethindrone acetate combination tablet from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ETYQA (ESTRADIOL AND NORETHINDRONE ACETATE)

Snippet

ORIG AP for ETYQA (ESTRADIOL AND NORETHINDRONE ACETATE)